131 related articles for article (PubMed ID: 15385935)
1. CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
Huang M; Wang Y; Collins M; Graves LM
Leukemia; 2004 Nov; 18(11):1857-63. PubMed ID: 15385935
[TBL] [Abstract][Full Text] [Related]
2. A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools.
Huang M; Wang Y; Collins M; Mitchell BS; Graves LM
Mol Pharmacol; 2002 Sep; 62(3):463-72. PubMed ID: 12181422
[TBL] [Abstract][Full Text] [Related]
3. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
Huang HM; Chiou HY; Chang JL
J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
[TBL] [Abstract][Full Text] [Related]
4. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
Zhang H; Cooney DA; Zhang MH; Ahluwalia G; Ford H; Johns DG
Cancer Res; 1993 Dec; 53(23):5714-20. PubMed ID: 7694793
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB
Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994
[TBL] [Abstract][Full Text] [Related]
6. Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.
Ford H; Cooney DA; Ahluwalia GS; Hao Z; Rommel ME; Hicks L; Dobyns KA; Tomaszewski JE; Johns DG
Cancer Res; 1991 Jul; 51(14):3733-40. PubMed ID: 1712247
[TBL] [Abstract][Full Text] [Related]
7. Regulation of equilibrative nucleoside uptake by protein kinase inhibitors.
Huang M; Wang Y; Mitchell BS; Graves LM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1445-50. PubMed ID: 15571274
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways.
Sawafuji K; Miyakawa Y; Kizaki M; Ikeda Y
Am J Hematol; 2003 Jan; 72(1):67-9. PubMed ID: 12508271
[TBL] [Abstract][Full Text] [Related]
9. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
Bierau J; Van Gennip AH; Leen R; Helleman J; Caron HN; Van Kuilenburg AB
Int J Cancer; 2003 Jan; 103(3):387-92. PubMed ID: 12471622
[TBL] [Abstract][Full Text] [Related]
10. The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines.
Bierau J; van Gennip AH; Helleman J; van Kuilenburg AB
Biochem Pharmacol; 2001 Oct; 62(8):1099-105. PubMed ID: 11597578
[TBL] [Abstract][Full Text] [Related]
11. Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy.
Verschuur AC; Van Gennip AH; Leen R; Muller EJ; Elzinga L; Voûte PA; Van Kuilenburg AB
Eur J Cancer; 2000 Mar; 36(5):627-35. PubMed ID: 10738128
[TBL] [Abstract][Full Text] [Related]
12. Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity.
Schimmel KJ; Gelderblom H; Guchelaar HJ
Curr Cancer Drug Targets; 2007 Aug; 7(5):504-9. PubMed ID: 17691910
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
Moosavi MA; Yazdanparast R; Lotfi A
Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
[TBL] [Abstract][Full Text] [Related]
14. Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.
Ford H; Driscoll JS; Hao Z; Dobyns KA; Rommel ME; Stowe E; Anderson JO; Plowman J; Waud WR; Johns DG
Biochem Pharmacol; 1995 Jan; 49(2):173-80. PubMed ID: 7840794
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells.
Agbaria R; Kelley JA; Jackman J; Viola JJ; Ram Z; Oldfield E; Johns DG
Oncol Res; 1997; 9(3):111-8. PubMed ID: 9220496
[TBL] [Abstract][Full Text] [Related]
16. Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
Huang M; Whang P; Lewicki P; Mitchell BS
Mol Pharmacol; 2011 Jul; 80(1):40-8. PubMed ID: 21464199
[TBL] [Abstract][Full Text] [Related]
17. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
Kohmura K; Miyakawa Y; Kawai Y; Ikeda Y; Kizaki M
J Cell Physiol; 2004 Mar; 198(3):370-6. PubMed ID: 14755542
[TBL] [Abstract][Full Text] [Related]
18. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase.
Kang GJ; Cooney DA; Moyer JD; Kelley JA; Kim HY; Marquez VE; Johns DG
J Biol Chem; 1989 Jan; 264(2):713-8. PubMed ID: 2910861
[TBL] [Abstract][Full Text] [Related]
19. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
Kawano T; Horiguchi-Yamada J; Saito S; Iwase S; Furukawa Y; Kano Y; Yamada H
Leuk Res; 2004 Jun; 28(6):623-9. PubMed ID: 15120940
[TBL] [Abstract][Full Text] [Related]
20. In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors.
Viola JJ; Agbaria R; Walbridge S; Oshiro EM; Johns DG; Kelley JA; Oldfield EH; Ram Z
Cancer Res; 1995 Mar; 55(6):1306-9. PubMed ID: 7882327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
